Chronic Myeloid Leukemia (CML) is a type of cancer of the white blood cells ... The drawback to this test is that it takes time (usually around 30 days) and doesn't always work. Fluorescent in situ ...

Researchers are exploring new treatment options for chronic myeloid leukemia (CML). Many treatments that have recently been studied or are currently under investigation are targeted therapy drugs.

About 9,560 new cases will be diagnosed with CML (5,610 in men and 3,950 in women) About 1,290 people will die of CML (740 men and 550 women) About 15% of all new cases of leukemia are chronic myeloid ...

Although it seems increasingly possible to select benign progenitors from the marrow or peripheral blood of CML patients, there is no evidence to show that autografting using any technique ...

Chronic myeloid leukemia (CML) is a type of blood cancer that affects the production of granulocytes (a kind of white blood cell) from the bone marrow. The Philadelphia chromosome is a specific ...

Fluorescence imaging is the visualization of fluorescent dyes or proteins as labels for molecular processes or structures. It enables a wide range of experimental observations including the ...

Blood malignancies provide unique opportunities for longitudinal tracking of disease evolution following therapeutic bottlenecks and for the monitoring of changes in anti-tumor immunity. The expanding ...

We used PCR‐based techniques to quantify telomere length, which has a lower accuracy than fluorescence‐in‐situ hybridization. However, we have previously compared our PCR approach to flow‐fluorescence ...

Ductal carcinoma in situ is a precursor of breast cancer that is usually treated with surgery, radiation therapy, and estrogen blockade. A new study suggests that watchful waiting might be safe for ...